Sotera Health Company (SHC)

NASDAQ: SHC · USD

$18.6

+0.13 (+0.7%)· Recorded snapshot

Market cap	5.3B
Revenue (ttm)	1.2B
Net income (ttm)	163.5M
EPS (ttm)	$0.57
Shares out	285.4M
P/E (trailing)	32.8x
P/E (forward)	18.2x
Volume	1,445,221
Beta	1.86

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2B
Net income (ttm): 163.5M
EPS (ttm): $0.57
P/E (trailing): 32.8x
P/E (forward): 18.2x
Market cap: 5.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	보유

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.2

P25 n/aP50 n/aP75 n/a

Trailing P/E32.8

P25 n/aP50 n/aP75 n/a

ROE27.8

P25 n/aP50 n/aP75 n/a

ROIC10.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHC indicators

Market & fundamental data

Available fields

260

Groups with data

Currency

USD

Showing 260 of 260 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001822479
Company name	Sotera Health Company
Country	United States
Country code	US
CUSIP number	83601L102
Earnings date	2026-11-03
Earnings time	bmo
Employees	3,000
Employees change	0
Employees growth	0%
Enterprise value	$7.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
Industry	Diagnostics & Research
IPO date	2020-11-20
Is primary listing	Yes
Is SPAC	No
ISIN number	US83601L1026
Last 10-K release date	2026-02-24
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$5.3B
Market cap category	Mid-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$18.63
Price currency	USD
Sector	Healthcare
SIC code	8090
Stock price date	2026-10-28
Symbol	SHC
U.S. state	Ohio
Website	https://soterahealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	19.4x
Average P/E ratio (3Y)	79.06x
Average P/E ratio (5Y)	77.41x
Earnings yield	3.05%
EV/Earnings	43.99x
EV/EBIT	16.02x
EV/EBITDA	12.47x
EV/FCF	63.8x
EV/Sales	5.91x
FCF / EV yield	1.57%
FCF yield	2.13%
Forward EV/Sales	5.61x
Forward P/E	18.18x
Forward P/S	4.12x
Graham number	5.45586
Graham upside	-70.51%
Industry forward P/E	30.92x
Industry P/E	50.57x
Lynch fair value	$14.18
Lynch upside	-23.36%
P/(FCF - SBC) ratio	69.86x
P/(OCF - SBC) ratio	20.7x
P/B ratio	7.93x
P/E ratio	32.84x
P/FCF ratio	46.84x
P/OCF ratio	18.07x
P/S ratio	4.34x
Price/EBITDA ratio	9.16x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	36.92%
EBITDA margin	47.41%
Effective tax rate	38.1%
FCF margin	9.27%
Gross margin	54.97%
Operating margin	36.92%
Pretax margin	21.72%
Profit margin	13.44%
Profit per employee	$54,492
Profitable quarters	5
Profitable years	3
Revenue per employee	$405,391
ROA	8.6%
ROA (5Y)	7.06%
ROCE	14.6%
ROE	27.78%
ROE (5Y)	2.23%
ROIC	10.78%
ROIC (5Y)	9.06%
SBC / revenue	3.05%
Tax / revenue	8.27%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	570.85%
EPS growth (Q)	569.49%
EPS growth (QoQ)	108.57%
EPS growth 5Y	74.97%
EPS growth quarters	4
EPS growth years	1
FCF growth	0%
FCF growth (Q)	60.56%
FCF growth 5Y	-2.41%
Gross profit growth	7.06%
Gross profit growth (Q)	6.81%
Gross profit growth 3Y	8.13%
Gross profit growth 5Y	6.53%
Net income growth	580.51%
Net income growth (Q)	573.74%
Net income growth (QoQ)	101.75%
Net income growth 5Y	78.48%
Net income growth quarters	4
Net income growth years	1
OCF growth	9.8%
OCF growth (Q)	54.13%
OCF growth (QoQ)	200.65%
OCF growth 5Y	7.65%
Operating income growth	23.47%
Operating income growth (Q)	17.28%
Operating income growth 3Y	15.9%
Operating income growth 5Y	10.27%
Revenue growth	8.15%
Revenue growth (Q)	9.19%
Revenue growth (QoQ)	14.76%
Revenue growth 3Y	7.6%
Revenue growth 5Y	6.66%
Revenue growth quarters	6
Revenue growth years	7

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-179.5M
Depreciation and amortization	$127.6M
EBIT	$449M
EBITDA	$576.6M
EPS	$0.57
FCF per share	$0.39
Financing cash flow	$-100.7M
Free cash flow	$112.7M
Free cash flow minus SBC	$75.6M
Gross profit	$668.5M
Income taxes	$100.6M
Investing cash flow	$-172.5M
Net borrowing	$-82.1M
Net cash flow	$22.5M
Net income	$163.5M
Operating cash flow minus SBC	$255.1M
Operating income	$449M
Revenue	$1.2B
Stock-based compensation	$37.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.79
Book value per share	$2.33
Debt / EBITDA	3.85
Debt / equity	3.41
Debt / FCF	20.12
Goodwill	$1.1B
Interest coverage	3.13
Long-term assets	$2.7B
Long-term liabilities	$2.4B
Net cash (debt)	$-1.9B
Net cash / market cap	-36.2%
Net debt / EBITDA	3.31
Net debt / equity	2.87
Net debt / FCF	16.96
Piotroski F-Score	7
Property, plant and equipment	$1.2B
Shareholders' equity	$665.6M
Tangible book value	$-695.8M
Tangible book value per share	$-2.44
Total assets	$3.3B
Total cash	$357M
Total debt	$2.3B
Total liabilities	$2.6B
WACC	11.29%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.37
Current assets	$646.5M
Current liabilities	$231.2M
Current ratio	2.8
Inventory turnover	8.63
Net working capital	$81.4M
Quick ratio	2.4
Working capital	$415.2M
Working capital turnover	3.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.36%
Dividend yield	0%
Shareholder yield	-1.36%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$17.16
1D price change	0.73%
1M price change	1.04%
1M total return	1.04%
1W price change	3.35%
1W total return	3.35%
1Y price change	10.89%
1Y return CAGR	10.9%
1Y total return	10.89%
20-day SMA	$18.10
200-day SMA	$17.01
3M price change	7.48%
3M total return	7.48%
3Y price change	48.12%
3Y return CAGR	13.99%
3Y total return	48.12%
50-day SMA	$18.55
50-day SMA vs 200-day SMA	50over200
52-week high	$19.85
52-week high date	2026-01-09
52-week low	$13.09
52-week low date	2026-03-30
5Y price change	-26.09%
5Y return CAGR	-5.87%
5Y total return	-26.09%
6M price change	17.2%
6M total return	17.2%
All-time high	$30.38
All-time high date	2021-03-15
All-time low	$5.78
All-time low date	2022-11-09
Average true range (ATR)	$0.47
Average volume	1.9M
Beta (1Y)	1.39
Beta (2Y)	1.26
Beta (5Y)	1.86
Change from 52-week high	-6.17%
Change from 52-week low	42.28%
Change from all-time high	-39.01%
Change from all-time low	220.59%
Change from open	1.06%
Day's gap	-0.32%
Dollar volume	$26.9M
High price	$18.79
Low price	$18.42
Monthly RSI	58.64
Open price	$18.43
Position in 52-week range	55.41%
Premarket change	0.05%
Premarket close	$18.49
Premarket price	$18.50
Premarket volume	223
Previous close	$18.49
Price vs 150-day SMA	7.99%
Price vs 20-day SMA	2.39%
Price vs 200-day SMA	8.94%
Price vs 50-day SMA	-0.08%
Relative volume	0.75
Return from IPO open	-31.48%
Return from IPO price	-19.57%
RSI	55.53
Sharpe ratio	0.36
Sharpe ratio (3Y)	0.4
Sharpe ratio (5Y)	0.1
Sortino ratio	0.77
Sortino ratio (3Y)	0.78
Sortino ratio (5Y)	0.32
Volume	1.4M
Weekly RSI	57.26
YTD price change	5.05%
YTD total return	5.05%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	200.8M
Float percentage	70.38%
Shares change (QoQ)	0.18%
Shares change (YoY)	1.36%
Shares held by insiders	2.19%
Shares held by institutions	70.57%
Shares outstanding	285.4M
Short % of float	7.34%
Short % of shares	5.17%
Short ratio	7.5 days

Deeper analysis on SHC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHC report

Is a complete SHC research report available?

No complete published report is available for Sotera Health Company (SHC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Sotera Health Company (SHC)

Price

Financial snapshot

Fair-value bridge

Latest news · SHC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHC

Frequently asked questions